New CRO in Hong Kong to feed China

By Kirsty Barnes

- Last updated on GMT

Related tags: Contract research organization, People's republic of china, China

A new contract research organization (CRO) has opened in Hong Kong
and will be the only clinical trial site outside of China with the
approval of China's State Food and Drug Administration (SFDA) to
run oncology trials.

The new CRO, Bridgetech Medical Technologies Research (BMTR) is part of a new venture between US firm Bridgetech Holdings International and the Chinese University of Hong Kong. Playing a part in the decision to open a CRO in the region was the fact that Hong Kong plays a strategically important role in China's healthcare development, according to Pro-vice-chancellor of the Chinese University Kenneth Young. In addition to running clinical trials the site will also help facilitate regulatory approval from the Chinese regulatory authorities, as well as the US Food and Drug Administration (FDA). The life science market in China is one of the fastest growing markets in the world and demand for contract services continues to escalate as the domestic pharma market continues to mature and many of the world's top pharma companies also begin to set up low-cost manufacturing operations in and around the country. Asia, led by China, has the largest pool of patients with cancer, cardiovascular and infectious diseases - therapeutic areas that are now accounting for 70 per cent of all new drugs.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars